The benefits and harms of breast cancer screening.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Economic benefit of expanding mammography screening for breast cancer in Colombia: A cost modelling analysis.Public health in practice (Oxford, England) · 2026
   Article
2. Income inequality in uptake of voluntary versus organised breast cancer screening: evidence from the British Household Panel Survey.BMC public health · 2018
   Article
3. Opportunistic mammography screening provides effective detection rates in a limited resource healthcare system.BMC cancer · 2015
   Article
4. Improving outcomes in breast cancer for low and middle income countries.World journal of surgery · 2015
   Review
5. Women's participation in breast cancer screening in France--an ethical approach.BMC medical ethics · 2014
   Article

Corrections and comments

• Commented on by
  The benefits and harms of breast cancer screening - Authors' reply.2013
• Comment on
  The benefits and harms of breast cancer screening: an independent review.2012

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as